Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.650
+0.100 (6.45%)
Feb 18, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Antibody-based Solutions
25.38M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
25.38M